LSTA
Lisata Therapeutics Inc

8,961
Loading...
Loading...
News
all
press releases
Earnings Outlook For Lisata Therapeutics
read more...
Benzinga·10mo ago
News Placeholder
More News
News Placeholder
Lisata Therapeutics Announces Q2 2024 Financial Results
Lisata Therapeutics (LSTA) has provided an update. Lisata Therapeutics, Inc. has recently shared its financial outcomes for the second quarter of 2...
TipRanks Financial Blog·1y ago
News Placeholder
Quest Diagnostics' Haystack Oncology Forges New MRD Deal
Quest Diagnostics' (NYSE: DGX) subsidiary, Haystack Oncology, and Lisata Therapeutics, Inc. (NASDAQ: LSTA) recently announced a research collaboration for using the Haystack MRD (minimal residual...
Benzinga·1y ago
News Placeholder
Lisata Stock Rallies More Than 30% YTD: Here's Why
Lisata Therapeutics, Inc.'s (NASDAQ: LSTA) lead pipeline candidate is certepetide (formerly known as LSTA1), which is being developed for treating a range of solid tumors. read more...
Benzinga·1y ago
News Placeholder
Lisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor Events
BASKING RIDGE, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) ( Lisata or the Company ), a clinical-stage pharmaceutical company developing innovative therapies...
Globe Newswire·1y ago
News Placeholder
Lisata Therapeutics (NASDAQ:LSTA) Trading 1.8% Higher
Lisata Therapeutics, Inc. (NASDAQ:LSTA Get Free Report)s share price traded up 1.8% during trading on Wednesday . The company traded as high as $3.27 and last traded at $3.23. 11,964...
Zolmax·1y ago
News Placeholder
Lisata Therapeutics Announces U.S. FDA Rare Pediatric Disease Designation Granted to LSTA1 for the Treatment of Osteosarcoma
Achieves critical first step toward priority review voucherBASKING RIDGE, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) ( Lisata or the Company ), a...
Globe Newswire·1y ago
News Placeholder
Lisata Therapeutics to Present at the Life Science Investor Forum on March 7
BASKING RIDGE, N.J., March 04, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) ( Lisata or the Company ), a clinical-stage pharmaceutical company developing innovative therapies...
Globe Newswire·2y ago
News Placeholder
Lisata Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
Phase 2b ASCEND trial fully enrolled and on track for top-line data in fourth quarter of 2024 Company affirms projection of operational funds into early 2026 Conference call scheduled for today at...
Globe Newswire·2y ago
News Placeholder
Lisata Therapeutics to Host Year-End 2023 Conference Call on Thursday, February 29, 2024 at 4:30 p.m. Eastern Time
BASKING RIDGE, N.J., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) ( Lisata or the Company ), a clinical-stage pharmaceutical company developing innovative therapies...
Globe Newswire·2y ago

Latest LSTA News

View

Advertisement. Remove ads.

Advertisement. Remove ads.